Clinical trial
Molecular Profile-related Individualized Targeted Therapy in Resected Pancreatic Cancer With High-Risk of Cancer Recurrence
NCT06228599 is registered in ClinicalTrials.gov with Medical College of Wisconsin as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Molecular Profile-related Individualized Targeted Therapy in Resected Pancreatic Cancer With High-Risk of Cancer Recurrence
- Lead sponsor
- Medical College of Wisconsin
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- February 29, 2024
- Completion date
- January 31, 2029
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pancreas cancer